AKL Therapeutics > News > Abstract published at EULAR 2020

Abstract published at EULAR 2020

An abstract on a series of uncontrolled patient cases evaluating the efficacy and safety of APPA in patients with osteoarthritis has been published at EULAR 2020

Treatment with APPA was reported as effective by 82.6% of patients, all of whom had failed to have an adequate response with standard prescribed medications.

Full abstract is available here.